Literature DB >> 25801872

Magnitude of blood pressure reduction and clinical outcomes in acute intracerebral hemorrhage: intensive blood pressure reduction in acute cerebral hemorrhage trial study.

Xia Wang1, Hisatomi Arima1, Emma Heeley1, Candice Delcourt1, Yining Huang1, Jiguang Wang1, Christian Stapf1, Thompson Robinson1, Mark Woodward1, John Chalmers1, Craig S Anderson2.   

Abstract

UNLABELLED: Evidence supports early intensive blood pressure (BP) lowering in acute intracerebral hemorrhage, but uncertainty persists over whether potential benefits and harms vary according to the magnitude of BP reduction. We aimed to determine whether larger systolic BP (SBP) reductions were associated with better outcomes in participants of the Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial (INTERACT2). INTERACT2 was an international, open, blinded end point, randomized controlled trial of patients with spontaneous intracerebral hemorrhage (<6 hours) and elevated SBP (150-220 mm Hg) assigned to intensive (target SBP <140 mm Hg) or guideline-recommended (SBP <180 mm Hg) treatment. Associations of BP reduction (baseline minus average of achieved SBP) during 3 time periods post randomization (15-60 minutes, 1-24 hours, and 2-7 days) on poor outcome (death or major disability) at 90 days were analyzed in multivariable logistic regression models with odds ratios and 95% confidence intervals. Larger SBP reductions within the first hour after randomization were associated with lower risks of poor outcome: compared with minimal reduction (<10 mm Hg), odds ratios were 0.80 (95% confidence interval, 0.63-1.02) for moderate (10-20 mm Hg) and 0.65 (0.52-0.82) for large (≥20 mm Hg) reductions (P trend <0.01). Similar associations were also observed for SBP reductions during 1 to 24 hours (P<0.01) and 2 to 7 days (P 0.02). No heterogeneity in associations for patients above or below baseline SBP 180 mm Hg was reported (P>0.30). Optimal recovery from intracerebral hemorrhage was observed in hypertensive patients who achieved the greatest SBP reductions (≥20 mm Hg) in the first hour and maintained for 7 days. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00716079.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  cerebral hemorrhage; clinical trial; hypertension; treatment outcome

Mesh:

Substances:

Year:  2015        PMID: 25801872     DOI: 10.1161/HYPERTENSIONAHA.114.05044

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  14 in total

1.  Modeling Stroke Patient Transport for All Patients With Suspected Large-Vessel Occlusion.

Authors:  Jessalyn K Holodinsky; Tyler S Williamson; Andrew M Demchuk; Henry Zhao; Luke Zhu; Michael J Francis; Mayank Goyal; Michael D Hill; Noreen Kamal
Journal:  JAMA Neurol       Date:  2018-12-01       Impact factor: 18.302

2.  Blood Pressure Management After Intracerebral Hemorrhage.

Authors:  Shoichiro Sato; Cheryl Carcel; Craig S Anderson
Journal:  Curr Treat Options Neurol       Date:  2015-12       Impact factor: 3.598

Review 3.  Therapies to Reduce Blood Pressure Acutely.

Authors:  Joseph B Miller; Harish Kinni; Ahmed Amer; Phillip D Levy
Journal:  Curr Hypertens Rep       Date:  2016-06       Impact factor: 5.369

Review 4.  Management of Acute Hypertensive Response in Intracerebral Hemorrhage Patients After ATACH-2 Trial.

Authors:  Shahram Majidi; Jose I Suarez; Adnan I Qureshi
Journal:  Neurocrit Care       Date:  2017-10       Impact factor: 3.210

Review 5.  Acute hypertensive response in patients with intracerebral hemorrhage pathophysiology and treatment.

Authors:  Adnan I Qureshi; Mushtaq H Qureshi
Journal:  J Cereb Blood Flow Metab       Date:  2017-08-16       Impact factor: 6.200

6.  Blood Pressure-Attained Analysis of ATACH 2 Trial.

Authors:  Adnan I Qureshi; Yuko Y Palesch; Lydia D Foster; William G Barsan; Joshua N Goldstein; Daniel F Hanley; Chung Y Hsu; Claudia S Moy; Mushtaq H Qureshi; Robert Silbergleit; Jose I Suarez; Kazunori Toyoda; Haruko Yamamoto
Journal:  Stroke       Date:  2018-05-22       Impact factor: 7.914

7.  2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.

Authors:  Tzung-Dau Wang; Chern-En Chiang; Ting-Hsing Chao; Hao-Min Cheng; Yen-Wen Wu; Yih-Jer Wu; Yen-Hung Lin; Michael Yu-Chih Chen; Kwo-Chang Ueng; Wei-Ting Chang; Ying-Hsiang Lee; Yu-Chen Wang; Pao-Hsien Chu; Tzu-Fan Chao; Hsien-Li Kao; Charles Jia-Yin Hou; Tsung-Hsien Lin
Journal:  Acta Cardiol Sin       Date:  2022-05       Impact factor: 1.800

Review 8.  Management of Spontaneous Intracerebral Hematoma.

Authors:  Motohiro Morioka; Kimihiko Orito
Journal:  Neurol Med Chir (Tokyo)       Date:  2017-08-15       Impact factor: 1.742

Review 9.  Blood pressure management in acute stroke.

Authors:  Jason P Appleton; Nikola Sprigg; Philip M Bath
Journal:  Stroke Vasc Neurol       Date:  2016-06-24

10.  Lowering blood pressure after acute intracerebral haemorrhage: protocol for a systematic review and meta-analysis using individual patient data from randomised controlled trials participating in the Blood Pressure in Acute Stroke Collaboration (BASC).

Authors:  Tom J Moullaali; Xia Wang; Lisa J Woodhouse; Zhe Kang Law; Candice Delcourt; Nikola Sprigg; Kailash Krishnan; Thompson G Robinson; Joanna M Wardlaw; Rustam Al-Shahi Salman; Eivind Berge; Else C Sandset; Craig S Anderson; Philip M Bath
Journal:  BMJ Open       Date:  2019-07-16       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.